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The proto-oncogene product c-Myc has a direct role in both
metazoan cell growth and division1–4. RNA polymerase III (pol
III) is involved in the generation of transfer RNA and 5S ribosomal
RNA, and these molecules must be produced in bulk to meet the
need for protein synthesis in growing cells5. We demonstrate here
that c-Myc binds to TFIIIB, a pol III-specific general transcrip-
tion factor, and directly activates pol III transcription. Chroma-
tin immunoprecipitation reveals that endogenous c-Myc is
present at tRNA and 5S rRNA genes in cultured mammalian
cells. These results suggest that activation of pol III may have a
role in the ability of c-Myc to stimulate cell growth.
Cell division requires a critical rate of growth (accumulation of
mass), which depends primarily on protein synthesis3. Myc activation
drives rapid increases in translation and growth, which precede DNA
replication and cell division3,6. Indeed, Myc in some contexts can
stimulate protein synthesis and growth independently of cell cycle
progression7–11. Conversely, Myc loss diminishes growth and protein
synthesis3,8,12. Many candidate Myc target genes encode ribosomal
proteins and translation factors6,13,14. Because pol III transcription is
tightly linked to growth, we tested whether it responds to c-Myc.
When c-Myc knockout and matched wild-type fibroblasts are
compared, the knockout fibroblasts show approximately sevenfold
lower expression of pol III transcripts from the B2 repetitive gene
family (Fig. 1a); the decrease is specific, as messenger RNA encoding
acidic ribosomal phosphoprotein (ARPP) P0 remains constant. Pol
III activity is therefore sensitive to the presence of endogenous c-Myc.
A tamoxifen-inducible c-Myc–oestrogen receptor (Myc–ER) fusion
stimulated B2 expression when introduced into the knockout cells by
retroviral transduction13. There was an increase of about 1.5-fold over
basal levels in the absence of tamoxifen, which reflects leakiness of the
conditional protein12,15; however, tamoxifen induced a further
increase in pol III transcript levels (Fig. 1b). This response was
not observed with the natural variant Myc-S, which lacks the
amino-terminal 100 residues of the transactivation domain15.
Pol III activity was also induced in primary human fibroblasts by
Myc–ER expressed from a retroviral vector15 (Fig. 1c). An intron-
specific primer was used in polymerase chain reaction with reverse
transcription (RT–PCR) reactions to assay levels of tRNA precursor,
which is processed very rapidly and so provides an assay of ongoing
transcriptional activity16. Precursor tRNALeu levels increase about
sevenfold in quiescent cells infected with Myc–ER relative to vector-
infected controls; a further increase occurs within 3 h of adding
tamoxifen. However, tamoxifen has no effect on cells carrying
empty vector. Similar results were obtained with tRNATyr (data
not shown). Activation of tRNA genes reaches 12-fold in the
presence of Myc–ER and tamoxifen, which is a more potent
response than the roughly 3.6-fold induction obtained in parallel
for the cyclin D2 gene, an established Myc target13. These effects
are specific, as the level of ARPP P0 mRNA is unchanged. Deletion
of residues 106–143 within the c-Myc transactivation domain
(DMyc–ER) prevents activation of both tRNA and cyclin D2 genes.
Several mechanisms might explain the responsiveness to c-Myc of
genes transcribed by pol III. In Rat1 cells, c-Myc was reported to
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induce transcription of the BN51 gene, which encodes a subunit of
pol III (ref. 17). However, c-Myc did not induce transcription of
BN51 in primary human fibroblasts (Fig. 2a). Furthermore, there is
no increase in the level of mRNAs encoding subunits of TFIIIC2,
a pol III-specific factor that is overexpressed in some tumours16.
c-Myc activation can provoke hyperphosphorylation of the retino-
blastoma (Rb) protein18. As Rb represses tRNA synthesis in a
phosphorylation-dependent manner19,20, we tested whether the
pol III response to c-Myc is Rb-dependent. Transfection of c-Myc
expression vector stimulates pol III transcription of the adenovirus
VA1 gene in immortalized fibroblasts from either wild-type or
Rb-knockout mice, without affecting a co-transfected SV40-CAT
control (Fig. 2b). The Rb-related protein p107 also represses pol III
transcription21; as c-Myc binds and neutralizes p107 (refs 22, 23), we
tested whether it continues to activate VA1 in the absence of the
entire Rb family (Fig. 2c). Robust and specific VA1 induction is
obtained in triple-knockout fibroblasts lacking Rb, p107 and p130.
We conclude that pol III regulation by c-Myc does not require the
Rb family.
The timing of tRNA induction after activation of Myc–ER
matches that of the cyclin D2 gene, a direct target of c-Myc13. In
contrast, indirect targets generally take longer to respond in this
system and S phase entry takes about 17 h (ref. 13). Because of the
rapidity of tRNA activation, we considered the possibility of a direct
interaction between c-Myc and the pol III machinery. Tamoxifen
treatment was carried out in the presence of 2 mg ml21 a-amanitin,
which specifically blocks pol II transcription: any effect seen under
these conditions cannot be a secondary response to induction of
genes transcribed by pol II. Previous studies indicate that Myc–ER
protein is active during the time course of the experiment13,24.
Whereas mRNA levels of cyclin D2 decline after a-amanitin treat-
ment, the more stable ARPP P0 transcript remains at a steady level
throughout the experiment. Although a-amanitin prevented c-Myc
activation of the cyclin D2 gene as expected, tRNALeu, tRNATyr and
5S rRNA were induced robustly (Fig. 3). This suggests that c-Myc
regulation of pol III templates does not require stimulation of
protein-encoding genes, and may therefore be direct.
We used chromatin immunoprecipitation (ChIP) to test whether
c-Myc associates with tRNA genes in vivo. In serum-starved fibro-
blasts transduced with empty vector, c-Myc was not detected at
the tRNALeu gene, although TFIIIC2 was bound (Fig. 4a). In
contrast, c-Myc was found at the tRNALeu gene in tamoxifen-treated
cells carrying the Myc–ER construct. These interactions are specific,
as a b-globin gene control showed little binding above the back-
ground levels observed with preimmune serum. In cycling fibro-
blasts, endogenous c-Myc is detected at tRNALeu, tRNATyr and 5S
rRNA genes, but not at the ARPP P0 gene (Fig. 4b). These
observations are not restricted to fibroblasts, as endogenous c-
Myc is also found at 5S rRNA and B2 genes in epithelial cells, but is
not detected at the p21Waf1 pol II promoter control (Fig. 4c).
Figure 2 Pol III activation by c-Myc does not require pocket proteins or induction of TFIIIC2
or BN51. a, RT–PCR of transcripts in WI38 cells transduced with empty vector or Myc–ER,
collected at the indicated times after 4-OHT induction. b, Primer extension analysis of
VA1 and pCAT expression in Rb / or Rb 2/2 fibroblasts co-transfected with control or
c-Myc expression vectors. c, As above, except with primary fibroblasts from wild-type
(WT) or Rb, p107 and p130 triple knockout (TKO) mice. Bar charts quantify these
experiments and independent repetitions, with VA1 expression normalized to the
co-transfected pCAT. Error bars indicate standard error of the mean.
                      
Figure 1 Pol III-transcribed genes respond to c-Myc in vivo. a, RNA from wild-type or
Myc-null fibroblasts12 was analysed for B2 and ARPP P0 expression by northern blotting.
b, Myc-null fibroblasts12 (KO) were transduced with vectors carrying Myc–ER or Myc-S–
ER. RNA extracted at the indicated times after treatment with 4-OHT was analysed for B2
and ARPP P0 expression by northern blotting. c, WI38 cells were transduced with empty
vector or vector carrying Myc–ER or DMyc–ER. RNA extracted at the indicated times after
4-OHT treatment was analysed by RT–PCR.
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Specific binding of c-Myc to tRNA genes is also observed in
epithelial and B cells (data not shown).
Although ChIP assays show c-Myc located at pol III templates
in vivo, these genes rarely contain matches to the E-box DNA
sequence recognized by Myc. We therefore investigated whether
c-Myc regulates pol III transcription by protein–protein inter-
actions in the absence of a DNA recognition site. TFIIIB is a
plausible target for c-Myc, as it contains TATA box-binding protein
(TBP)25, and the transactivation domain of c-Myc is known to bind
TBP23,26. Indeed, TBP and the TFIIIB-specific subunit Brf1 are
retained from extracts by beads carrying glutathione S-transferase
(GST) fused to residues 1–262 of c-Myc encompassing its transacti-
vation domain (GST–Myc-N262) (Fig. 5a). Binding is specific, as
neither TBP nor Brf1 associate with GST alone or the carboxy-
terminal 92 residues of c-Myc containing its DNA-binding and
dimerization domain (GST–Myc-C92). Nuclear extracts that have
been preincubated with GST–Myc-N262 are depleted of a factor
required for pol III transcription (Fig. 5b). Addition of a TFIIIB
fraction can fully restore tRNA expression, whereas adding pol III
does not. We conclude that TFIIIB binds specifically to the tran-
scriptional regulatory domain of c-Myc. This is consistent with
the fact that induction of tRNA genes in vivo requires this domain
(Fig. 1).
Figure 4 ChIP assays show that c-Myc interacts with tRNA, 5S rRNA and B2 genes in vivo.
a, WI38 cells transduced with Myc–ER or empty vector (pB) were exposed to 4-OHT for
12 h before crosslinking. The ChIP assay used anti-Myc antibody N-262, anti-TFIIIC110
antibody 4286 (ref. 16) or preimmune serum. b, ChIP assay using Balb/c 3T3 cells and
antibodies 9E10 against c-Myc, M-19 against TAFI48, BN51 against pol III and MTBP-6
against TBP30. c, ChIP assay using ROSE 199 ovarian epithelial cells16 and antibodies F-7
against HA, 9E10 against c-Myc, 128 against Brf 20, BN51 against pol III and MTBP-6
against TBP30.
Figure 5 TFIIIB interacts with the N-terminal domain of c-Myc. a, Pull-down assay with
GST, GST–Myc-C92 or GST–Myc-N262, and immunoblotted for HA-tagged Brf and TBP.
b, Transcription of tRNALeu with extracts depleted of proteins binding to GST or GST–Myc-
N262 and supplemented with 2 ml and 4 ml of pol III (lanes 5 and 6) or 2 ml and 4 ml of
TFIIIB (lanes 7 and 8). c, HeLa extract immunoprecipitated using antibodies against Rb,
E7, cyclin D1 and c-Myc; precipitates were immunoblotted for Brf. d, HeLa extract
mock-depleted or immunodepleted with antibodies against TFIIB, TBP or c-Myc was used
to transcribe VA1. e, Crude TFIIIB was chromatographed on MonoQ, and gradient-eluted
fractions were immunoblotted for c-Myc and assayed for TFIIIB transcriptional activity with
VA1 template.
Figure 3 Activation of pol III transcription by c-Myc does not depend on induction of
pol II transcription. WI38 cells were transduced with retroviral vector carrying c-Myc–ER,
serum-starved and then treated with 2 mg ml21 a-amanitin 1 h before induction
with 200 nM 4-OHT. RNA was extracted at the indicated times after induction and
analysed by RT–PCR for tRNATyr, tRNALeu, 5S rRNA, cyclin D2 and ARPP P0 transcripts.
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Co-immunoprecipitation reveals that endogenous c-Myc associ-
ates stably with TFIIIB at physiological ratios (Fig. 5c). Anti-Rb
antibody provides a positive control, as the Rb–TFIIIB interaction is
well documented5,20,21, whereas antibodies against E7 and cyclin D1
serve as negative controls. As with Rb, the Brf1 subunit of TFIIIB
immunoprecipitated together with monoclonal antibody against
c-Myc. In contrast, anti-Myc antibody did not immunoprecipitate
either TFIIIC2 or pol III (data not shown). Transcription assays
carried out with immunodepleted extract show that binding of
endogenous c-Myc to TFIIIB is functionally significant. Thus,
extracts depleted with anti-Myc antibody display reduced VA1
transcription, albeit less marked than TBP-depleted control
(Fig. 5d). In contrast, mock-depletion or immunodepletion of the
pol II-specific factor TFIIB has little effect. Independent support for a
stable interaction comes from the finding that endogenous c-Myc
fractionates together with TFIIIB activity on several columns, such as
the MonoQ gradient in Fig. 5e. We conclude that the transactivation
domain of c-Myc binds stably and specifically to the TFIIIB complex.
Identification of direct targets is a current priority of Myc
research27,28. The level of tRNA induction by Myc–ER exceeds the
weak transactivation often shown by established Myc targets, such as
cyclin D2 (Fig. 1c). Furthermore, pol III activity is severely compro-
mised in c-myc2/2 cells (Fig. 1a), consistent with the interaction
between endogenous c-Myc and TFIIIB. This interaction may allow
recruitment of coactivators and chromatin-modifying activities, or it
might block effects of negative regulators of the pol III machinery.
The ability of Myc to induce tRNA and 5S rRNA biosynthesis may be
expected to impact strongly on cell growth. Previous studies have
indicated that a substantial number of putative Myc target genes,
transcribed by pol II, are involved in metabolism and translation6,13,14.
The capacity to activate both pol II- and pol III-transcribed genes
might allow Myc to control growth by coordinately inducing the
various components of the protein synthetic apparatus through
parallel effects on independent transcription systems. A
Methods
Myc induction
Myc-null rat fibroblasts12 and WI38 human fibroblasts were transduced as described
previously13,15 with empty pBABEpuro retroviral vector or vectors carrying Myc–ER, Myc-S–
ER, or DMyc–ER. They were selected with puromycin for 3 days. Cells were then serum-
starved for 48 h to downregulate endogenous c-myc expression and then treated with
200 nM 4-hydroxy-tamoxifen (4-OHT).
Gene expression assays
We carried out northern blots as described previously21. RT–PCR of tRNALeu, tRNATyr, 5S
rRNA, TFIIIC220, TFIIIC110 and ARPP P0 transcripts was conducted as described
previously16. RT–PCR of cyclin D2 mRNA used primers 5
0
-CTGCCCCCACCTAGATC
ATA-3
0
and 5
0
-TCCCTTATGCTGTACTTCAAATAGG-3
0
; cycling parameters were 94 8C
for 90 s, 94 8C for 15 s, 62 8C for 23 s, 72 8C for 30 s, and 72 8C for 5 min. RT–PCR of BN51
mRNA used primers 5
0
-CCTACACAGTCTGTACCCTGG-3
0
and 5
0
-GGCATATTTCGAG
TGTCGTTCC-3 0 ; cycling parameters were 95 8C for 150 s, 95 8C for 30 s, 68 8C for 30 s,
72 8C for 30 s, and 72 8C for 5 min. Primer extension analyses of transfected pVA1 and
pCAT were carried out as described previously20.
Chromatin immunoprecipitation
Cells (roughly 2 £ 107 per immunoprecipitation) were collected and washed with ice-cold
PBS and then crosslinked for 10 min at 37 8C in 10 ml 0.5% NP-40/PBS containing 1%
formaldehyde. Crosslinked cells were washed with ice-cold 0.5% NP-40/PBS and
incubated for 30 min with 40 ml of high salt buffer (0.5% NP-40, PBS, 1 M NaCl). Further
washing with 0.5% NP-40/PBS was followed by hypotonic disruption for 30 min in 40 ml
of low salt buffer (0.1% NP-40, 10 mM TrisHCl, pH 8.0, 1 mM EDTA, 0.1 M NaCl). After
centrifugation at 478g for 10 min, nuclei were obtained with 10 strokes through a 23-gauge
needle and re-centrifuged. Nuclei were resuspended in 2.7 ml of low salt buffer and lysed
with 300 ml of 20% sarkosyl. Samples were transferred to a sucrose cushion and spun for
10 min at 4,000g. After resuspending the pellet in 3 ml of TE (10 mM Tris, pH 8.0, 1 mM
EDTA), the process was repeated. After resuspension in 2 ml of TE, genomic DNA was
sheared by sonication (Branson sonifier 250, 10 £ 10 s, duty cycle 30%). Sonicated
material was adjusted with 1/10 volume of £11 NET (1.65 M NaCl, 5.5 mM EDTA, 5.5%
NP-40, 550 mM TrisCl, pH 7.4) and immunoprecipitated overnight at 4 8C with 20 ml
(4 mg) of antibody. Protein A or protein G Sepharose beads were added for a further 2 h
incubation and then recovered on Polyprep columns (BioRad). After washing twice with
10 ml of RIPA buffer (50 mM TrisHCl, pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5%
deoxycholate, 1% NP-40), twice with 10 ml of LiCl buffer (10 mM TrisHCl, 250 mM LiCl,
0.5% NP-40, 0.5% deoxycholate, 1 mM EDTA, pH 8.0) and twice with 10 ml TE, beads
were transferred to 1.5-ml tubes and immunoprecipitated material was eluted twice with
200 ml of 1% SDS in TE. To isolate precipitated DNA, proteins and antibodies were
degraded by proteinase K treatment overnight at 42 8C. DNA was extracted twice using
phenol/chloroform/isoamylalcohol and ethanol-precipitated. Immunoprecipitated DNA
was quantified by PCR performed on the input and bound fractions, using primers
5 0 -GAGGACAACGGGGACAGTAA-3 0 and 5 0 -TCCACCAGAAAAACTCCAGC-3 0 for
tRNALeu and 5
0
-GACAGGTACGGCTGTCATCA-3
0
and 5
0
-AACGGCAGACTTCTCCT
CAG-3 0 for the b-globin control, as described29. PCR of the p21 promoter used primers
5
0
-GCCTCCTTTCTGTGCCTGA-3
0
and 5
0
-CCAGCCCTTGGATGGTTT-3
0
; cycling
parameters were 95 8C for 3 min, 35 cycles of 95 8C for 1 min, 52 8C for 1 min and 72 8C for
1 min, and 72 8C for 5 min. B2 gene PCR used primers 5 0 -GGGGCTGGAGAGATGGCT-3 0
and 5
0
-CCATGTGGTTGCTGGGAT-3
0
; cycling parameters were 95 8C for 3 min, 24 cycles
of 95 8C for 30 s, 58 8C for 30 s and 72 8C for 30 s, and 72 8C for 5 min. Other primers and
amplification conditions have been described16.
Pull-down, co-immunoprecipitation and immunodepletion
Pull-down assays were carried out as described previously21 with extracts of Chinese
hamster ovary (CHO) cells expressing haemagglutinin (HA)-tagged Brf1. These were
incubated for 3 h on ice with glutathione-agarose beads carrying GST alone, GST–Myc-
C92 or GST–Myc-N262. After pelleting and washing, beads were probed by
immunoblotting with antibodies F-7 against HA and 58C9 against TBP. Equal amounts of
depleted supernatants were used in transcription assays (Fig. 5b).
Immunoprecipitations were carried out as described21 using monoclonal antibodies
against Rb (G3–245; Pharmingen), E7 (TVG710Y), cyclin D1 (R-124) and c-Myc (9E10),
and precipitates were immunoblotted for Brf1 with antibody 128 (ref. 20). HeLa extract
was immunodepleted for 2 h on ice with protein G Sepharose beads alone (mock) or
carrying antibodies against TFIIB (C-18), TBP (MTBP-6) or c-Myc (9E10). Equal
amounts of immunodepleted extract were then used for transcription (Fig. 5d).
Antibodies N-262, 9E10, F-7, TVG710Y, R-124, 58C9, C-18 and M-19 were obtained from
Santa Cruz Biotechnologies.
Fractionation and in vitro transcription
In vitro transcription assays were carried out as described previously30. Pol III and TFIIIB
fractions added in Fig. 5b were A25 (1.0) and A25 (0.15), respectively: these fractions, as
well as PC-B and PC-C fractions, have been described previously30. Gradient
chromatography on MonoQ was conducted as described previously30 with PC-B input;
fractions were immunoblotted for c-Myc with 9E10 antibody, and assayed for TFIIIB
activity in transcriptions reconstituted with PC-C fraction containing pol III and TFIIIC.
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In Fig. 2b of this Letter, the third bar (dark grey) from the left was
incorrectly shown. Its allopatric diversity value should have been
0.007 not 0.19. This error does not alter the conclusions of the
paper. A
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In this Letter, the numbering on the middle panel of Fig. 2b was
misaligned. The figure should have appeared as shown.
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